These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Scleroderma with an update about clinico-pathological correlation. Rongioletti F; Ferreli C; Atzori L; Bottoni U; Soda G G Ital Dermatol Venereol; 2018 Apr; 153(2):208-215. PubMed ID: 29368844 [TBL] [Abstract][Full Text] [Related]
24. [Differential diagnosis of scleroderma-like changes in the skin]. Pokorný M Cesk Dermatol; 1973 Oct; 48(5):347-50. PubMed ID: 4762465 [No Abstract] [Full Text] [Related]
25. Direct immunofluorescence in the diagnosis of scleroderma syndromes. Winkelmann RK; Carapeto FJ; Jordon RE Br J Dermatol; 1977 Mar; 96(3):231-8. PubMed ID: 322691 [TBL] [Abstract][Full Text] [Related]
26. Scleroderma--clinical aspects. Black CM J Intern Med; 1993 Aug; 234(2):115-8. PubMed ID: 8340733 [No Abstract] [Full Text] [Related]
27. [Antinuclear antibodies in mesenchymal scleroderma and progressive systemic sclerosis (author's transl)]. Sugiura M; Hashimoto T; Kurihara S; Nishikawa T; Hatano H Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):935-7. PubMed ID: 7012401 [No Abstract] [Full Text] [Related]
28. [Characteristics of circumscribed scleroderma in children and its relation to systemic scleroderma]. Vlasova TM Pediatriia; 1988; (3):53-6. PubMed ID: 3380619 [No Abstract] [Full Text] [Related]